Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

Dermoscopy is a useful, low-cost method for diagnosing various types of hair loss disorders known as Cicatricial Alopecia.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Progeroid mouse models show signs of early aging similar to humans, helping us understand aging better.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Hair loss in lupus patients indicates higher disease activity.

Consider necrolytic acral erythema in similar cases and treat with oral zinc sulfate.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Different rheumatological diseases can cause specific skin problems.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

A woman with severe hair loss was successfully treated with the drug adalimumab.